behaviour change

Patients

pharmaphorum podcast Episode 234, Amy Bucher, Lirio

Delivering the right behavioural ingredients for the moment,...

Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.

Digital

Stethoscope and UK flag with NHS on wooden blocks spelled out on top

Six ways the NHS can become the UK’s greatest testbed for te...

There are six priorities that would turn the NHS into the UK’s flagship testbed for innovation.

Sales & Marketing

The Omni Advantage: A concise roadmap for change, for the pe...

The book launch for pharma industry veteran and award-winning businesswoman Merhnaz Campbell’s The Omni Advantage: Accelerating the Behavioural Change with Omnichannel in Pharma Sales E

Market Access

Localisation: Tailoring global campaigns for local success

When it comes to the pharmaceutical industry, a company’s marketing or educational efforts require not just a stellar set of global plans and materials, but also the ability to adapt global

Digital

Designing for behaviour change: The key to success in digita...

As discussed at the recent World Without Disease Summit, our lifestyle, environment, society, and even biology often work against us.

Views & Analysis

Is behavioural science the new capability every pharma company should be building

Behaviour science: the new capability every pharma company s...

Mark Lightowler takes a look at why medical interventions are evolving beyond drugs to also help patients change behaviours that impact their disease.